Stock Picks for Tuesday
Now that the S&P 500 (SPY) is up in 2025, investors have several technology stocks to consider. To diversify, investors may consider companies in the parcel shipping market while avoiding energy positions.Uber (UBER) closed at a new high on May 16. The company demonstrated flagship products at its yearly GO-GET event. It is launching Route Share, a new option that offers riders cheap rates.In the food delivery segment, Uber Eats will offer Savings Slider. Users may save money on groceries by enabling proactive price comparisons and substitutions.Investors may double down on the artificial intelligence and magnificent seven names. Microsoft (MSFT), Meta Platforms (META), and Amazon (AMZN) are the most appealing picks. Round out the holdings by considering Oracle (ORCL), Broadcom (AVGO), Qualcomm (QCOM), and Block (XYZ).Block is a speculative idea. The stock faces resistance in the $60 range, after trading as low as $44.27 recently. In the first quarter, Block posted weak Cash App Card spend data. Looking ahead, it is forecasting softness due to the macroeconomic environment.In the shipping sector, FedEx (FDX) and UPS are compelling buys. The government cut tariffs on Chinese imports for 90 days. In the energy sector, be wary of EQT after the stock’s recent highs. Antero Resources (AR) trades near the peak in the $40 range. Consider booking profits in case AR stock pulls back.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


